Climaco John M 4
4 · CNS Pharmaceuticals, Inc. · Filed Apr 14, 2023
Insider Transaction Report
Form 4
Climaco John M
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-04-12$0.69/sh+15,000$10,409→ 45,010 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.677 to $0.70. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.